Impact BioMedical Inc. Common Stock (IBO)
Stock · AMEX · Health Care
$2.68as of 10/16/2026
Price chart
Active signals
IBO Signal Track Record
How signals performed across all stocks →What IBO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 10 | -6.3% | 40% | September 2, 2026 |
| Bollinger Band Breakout | 5 | -8.1% | 20% | September 17, 2026 |
| Bollinger Band Breakdown | 5 | -4.0% | 20% | June 25, 2026 |
| 200-Day Moving Average TouchActive now | 4 | -0.5% | 50% | June 15, 2026 |
| Any 20-session window (baseline) | -4.0% | 39% |
Computed by MarketWall from daily closing prices since July 3, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About IBO
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflamma…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 2
- Website
- www.impactbiomedinc.com/
Fundamentals
- 1-day range
- $5.62$6.5
- Market cap
- $48.61M
- P/E (trailing)
- 61.61
- P/E (forward)
- —
- EPS (trailing)
- $-0.09
- Dividend yield
- —
- Beta
- -1.36
- Avg. volume
- 11.0K
How Impact BioMedical Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 11, 2026 · via SEC EDGAR / Finnhub
Impact BioMedical Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- IBOImpact BioMedical Inc. Common Stock$2.68▼ 15.14%Market cap $48.61MP/E 61.61$4.67$10.47
- TCRTAlaunos Therapeutics Inc. Common Stock$2.63▲ 20.64%Market cap $48.60MP/E —$0.719$4.5
- MCRBSeres Therapeutics Inc. Common Stock$2.46▼ 2.77%Market cap $48.42MP/E —$2.8$29.98
- MREOMereo BioPharma Group plc American Depositary Shares$0.303▼ 1.94%Market cap $47.46MP/E —$0.2$2.37
- FLNAFilana Therapeutics Inc. Common Stock$0.7▼ 7.89%Market cap $46.33MP/E —$0.6701$2.27
- CNTXContext Therapeutics Inc. Common Stock$0.244▲ 1.24%Market cap $46.31MP/E —$0.2358$3.62
- SCYXSCYNEXIS Inc. Common Stock$3.67▼ 6.14%Market cap $51.64MP/E —$3.53$9.12
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| IBO Impact BioMedical Inc. Common Stock | $48.61M | 61.61 | $2.68 | ▼ 15.14% | $4.67$10.47 |
| TCRT Alaunos Therapeutics Inc. Common Stock | $48.60M | — | $2.63 | ▲ 20.64% | $0.719$4.5 |
| MCRB Seres Therapeutics Inc. Common Stock | $48.42M | — | $2.46 | ▼ 2.77% | $2.8$29.98 |
| MREO Mereo BioPharma Group plc American Depositary Shares | $47.46M | — | $0.303 | ▼ 1.94% | $0.2$2.37 |
| FLNA Filana Therapeutics Inc. Common Stock | $46.33M | — | $0.7 | ▼ 7.89% | $0.6701$2.27 |
| CNTX Context Therapeutics Inc. Common Stock | $46.31M | — | $0.244 | ▲ 1.24% | $0.2358$3.62 |
| SCYX SCYNEXIS Inc. Common Stock | $51.64M | — | $3.67 | ▼ 6.14% | $3.53$9.12 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar LimitedYahoo · 9/16/2026
- Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)Yahoo · 9/16/2026
- CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)Yahoo · 9/15/2026
- Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)Yahoo · 9/11/2026
- Impact BioMedical Announces 1-For-12.62 Reverse Stock Split, Reducing Shares Outstanding From ~107.8M To ~8.54M, Effective Sept. 23Benzinga · 9/11/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 3.10M
- Total value held
- $1.86M
- Institutional holders
- 19
- Unknown1.19M
- Unknown708.2K
- Unknown607.9K
- Unknown259.9K
- Unknown243.9K
- Unknown37.4K
- Unknown32.4K
- Unknown10.0K
- Unknown9.3K
- Unknown1.8K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Impact BioMedical (IBO) noted in after‑hours health‑care stock moves
IBO was listed among twelve health‑care companies that showed price movement in Wednesday’s after‑market session, according to Benzinga. The activity highlights recent investor interest in the stock. The move occurs while the share trades near its recent support level of $0.47.
Impact BioMedical (IBO) noted in after‑hours health‑care stock moves. IBO was listed among twelve health‑care companies that showed price movement in Wednesday’s after‑market session, according to Benzinga. The activity highlights recent investor interest in the stock. The move occurs while the share trades near its recent support level of $0.47.